Fig. 5
From: Measuring luteinising hormone pulsatility with a robotic aptamer-enabled electrochemical reader
Distinguishing patient cohorts by LH pulsatility profiles using RAPTER and BSA. a RAPTER setting for the measurement of clinical samples. Illustration of the measurement programme design. b Bland–Altman analysis for the comparision of clinical assay result and aptamer assay result. c Linear regression of all the datasets in three patient cohorts for the comparison of RAPTER performance with clinical standard immunochemical assay. d–f Individual LH pulsatility profiles in women with menopause (d), healthy females (e) and hypothalamic amenorrhoea (f) obtained by RAPTER (red) and clinical assay (blue). g–i Pulse interval analysis in women with menopause (g), healthy females (h) and hypothalamic amenorrhoea (HA) (i) obtained by RAPTER (red) and clinical assay (blue). Source data are provided as a Source Data file
